▶ 調査レポート

世界のモルシドミン市場インサイト・予測(~2027年)

• 英文タイトル:Global Molsidomine Market Insights and Forecast to 2027

QYResearchが調査・発行した産業分析レポートです。世界のモルシドミン市場インサイト・予測(~2027年) / Global Molsidomine Market Insights and Forecast to 2027 / QY2108PAL3992資料のイメージです。• レポートコード:QY2108PAL3992
• 出版社/出版日:QYResearch / 2021年8月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、99ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Multi User¥1,087,800 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査資料はモルシドミンの世界市場の現状について調査・分析し、2027年までの市場を予測しました。モルシドミンの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模(錠剤、エアロゾル)、用途別市場規模(病院、薬局、その他)、主要地域別市場規模(北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ)、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。

・モルシドミンの世界市場概要
・メーカー別の競争状況、市場シェア
・モルシドミンの種類別市場規模:錠剤、エアロゾル
・モルシドミンの用途別市場規模:病院、薬局、その他
・北米のモルシドミン市場規模2016-2027:種類別、用途別、国別(アメリカ、カナダ)
・ヨーロッパのモルシドミン市場規模2016-2027:種類別、用途別、国別(ドイツ、フランス、イギリス)
・アジアのモルシドミン市場規模2016-2027:種類別、用途別、国別(日本、中国、インド、韓国)
・中南米のモルシドミン市場規模2016-2027:種類別、用途別、国別(メキシコ、ブラジル)
・中東・アフリカのモルシドミン市場規模2016-2027:種類別、用途別、国別(トルコ、サウジアラビア)
・企業情報:AdvaCare、China Resources Double-Crane Pharmaceutical Co., Ltd.、Shanghai Zhonghua Pharmaceutical Co., Ltd.、Beijing Hyderun Pharmaceutical Group Co., Ltd.、Heilongjiang Fulekang Pharmaceutical Co., Ltd.、Taj Life Sciences、Sanofi
・モルシドミンのバリューチェーン・販売チャネル分析
・モルシドミンの世界市場動向

Molsidomine is a vasodilator drug,Is a vasodilator drug and used for the prevention and long-term treatment of stable and unstable angina pectoris, with or without left heart failure. It is also used to treat angina in the context of an acute myocardial infarction.

Market Analysis and Insights: Global Molsidomine Market
The global Molsidomine market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Molsidomine Scope and Segment
Molsidomine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Molsidomine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Tablet
Aerosol

Segment by Application
Hospital
Pharmacy
Others

By Company
AdvaCare
China Resources Double-Crane Pharmaceutical Co., Ltd.
Shanghai Zhonghua Pharmaceutical Co., Ltd.
Beijing Hyderun Pharmaceutical Group Co., Ltd.
Heilongjiang Fulekang Pharmaceutical Co., Ltd.
Taj Life Sciences
Sanofi

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Molsidomine Product Introduction
1.2 Market by Type
1.2.1 Global Molsidomine Market Size Growth Rate by Type
1.2.2 Tablet
1.2.3 Aerosol
1.3 Market by Application
1.3.1 Global Molsidomine Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Molsidomine Sales Estimates and Forecasts 2016-2027
2.2 Global Molsidomine Revenue Estimates and Forecasts 2016-2027
2.3 Global Molsidomine Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Molsidomine Regions by Sales
2.4.1 Global Top Molsidomine Regions by Sales (2016-2021)
2.4.2 Global Top Molsidomine Regions by Sales (2022-2027)
2.5 Global Top Molsidomine Regions by Revenue
2.5.1 Global Top Molsidomine Regions by Revenue (2016-2021)
2.5.2 Global Top Molsidomine Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global Molsidomine Sales by Manufacturers
3.1.1 Global Top Molsidomine Manufacturers by Sales (2016-2021)
3.1.2 Global Top Molsidomine Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Molsidomine Sales in 2020
3.2 Global Molsidomine Revenue by Manufacturers
3.2.1 Global Top Molsidomine Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Molsidomine Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Molsidomine Revenue in 2020
3.3 Global Molsidomine Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Molsidomine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Molsidomine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Molsidomine Sales by Type
4.1.1 Global Molsidomine Historical Sales by Type (2016-2021)
4.1.2 Global Molsidomine Forecasted Sales by Type (2022-2027)
4.1.3 Global Molsidomine Sales Market Share by Type (2016-2027)
4.2 Global Molsidomine Revenue by Type
4.2.1 Global Molsidomine Historical Revenue by Type (2016-2021)
4.2.2 Global Molsidomine Forecasted Revenue by Type (2022-2027)
4.2.3 Global Molsidomine Revenue Market Share by Type (2016-2027)
4.3 Global Molsidomine Price by Type
4.3.1 Global Molsidomine Price by Type (2016-2021)
4.3.2 Global Molsidomine Price Forecast by Type (2022-2027)

5 Market Size by Application
5.1 Global Molsidomine Sales by Application
5.1.1 Global Molsidomine Historical Sales by Application (2016-2021)
5.1.2 Global Molsidomine Forecasted Sales by Application (2022-2027)
5.1.3 Global Molsidomine Sales Market Share by Application (2016-2027)
5.2 Global Molsidomine Revenue by Application
5.2.1 Global Molsidomine Historical Revenue by Application (2016-2021)
5.2.2 Global Molsidomine Forecasted Revenue by Application (2022-2027)
5.2.3 Global Molsidomine Revenue Market Share by Application (2016-2027)
5.3 Global Molsidomine Price by Application
5.3.1 Global Molsidomine Price by Application (2016-2021)
5.3.2 Global Molsidomine Price Forecast by Application (2022-2027)

6 North America
6.1 North America Molsidomine Market Size by Type
6.1.1 North America Molsidomine Sales by Type (2016-2027)
6.1.2 North America Molsidomine Revenue by Type (2016-2027)
6.2 North America Molsidomine Market Size by Application
6.2.1 North America Molsidomine Sales by Application (2016-2027)
6.2.2 North America Molsidomine Revenue by Application (2016-2027)
6.3 North America Molsidomine Market Size by Country
6.3.1 North America Molsidomine Sales by Country (2016-2027)
6.3.2 North America Molsidomine Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada

7 Europe
7.1 Europe Molsidomine Market Size by Type
7.1.1 Europe Molsidomine Sales by Type (2016-2027)
7.1.2 Europe Molsidomine Revenue by Type (2016-2027)
7.2 Europe Molsidomine Market Size by Application
7.2.1 Europe Molsidomine Sales by Application (2016-2027)
7.2.2 Europe Molsidomine Revenue by Application (2016-2027)
7.3 Europe Molsidomine Market Size by Country
7.3.1 Europe Molsidomine Sales by Country (2016-2027)
7.3.2 Europe Molsidomine Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific Molsidomine Market Size by Type
8.1.1 Asia Pacific Molsidomine Sales by Type (2016-2027)
8.1.2 Asia Pacific Molsidomine Revenue by Type (2016-2027)
8.2 Asia Pacific Molsidomine Market Size by Application
8.2.1 Asia Pacific Molsidomine Sales by Application (2016-2027)
8.2.2 Asia Pacific Molsidomine Revenue by Application (2016-2027)
8.3 Asia Pacific Molsidomine Market Size by Region
8.3.1 Asia Pacific Molsidomine Sales by Region (2016-2027)
8.3.2 Asia Pacific Molsidomine Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia

9 Latin America
9.1 Latin America Molsidomine Market Size by Type
9.1.1 Latin America Molsidomine Sales by Type (2016-2027)
9.1.2 Latin America Molsidomine Revenue by Type (2016-2027)
9.2 Latin America Molsidomine Market Size by Application
9.2.1 Latin America Molsidomine Sales by Application (2016-2027)
9.2.2 Latin America Molsidomine Revenue by Application (2016-2027)
9.3 Latin America Molsidomine Market Size by Country
9.3.1 Latin America Molsidomine Sales by Country (2016-2027)
9.3.2 Latin America Molsidomine Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Molsidomine Market Size by Type
10.1.1 Middle East and Africa Molsidomine Sales by Type (2016-2027)
10.1.2 Middle East and Africa Molsidomine Revenue by Type (2016-2027)
10.2 Middle East and Africa Molsidomine Market Size by Application
10.2.1 Middle East and Africa Molsidomine Sales by Application (2016-2027)
10.2.2 Middle East and Africa Molsidomine Revenue by Application (2016-2027)
10.3 Middle East and Africa Molsidomine Market Size by Country
10.3.1 Middle East and Africa Molsidomine Sales by Country (2016-2027)
10.3.2 Middle East and Africa Molsidomine Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 AdvaCare
11.1.1 AdvaCare Corporation Information
11.1.2 AdvaCare Overview
11.1.3 AdvaCare Molsidomine Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 AdvaCare Molsidomine Product Description
11.1.5 AdvaCare Recent Developments
11.2 China Resources Double-Crane Pharmaceutical Co., Ltd.
11.2.1 China Resources Double-Crane Pharmaceutical Co., Ltd. Corporation Information
11.2.2 China Resources Double-Crane Pharmaceutical Co., Ltd. Overview
11.2.3 China Resources Double-Crane Pharmaceutical Co., Ltd. Molsidomine Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 China Resources Double-Crane Pharmaceutical Co., Ltd. Molsidomine Product Description
11.2.5 China Resources Double-Crane Pharmaceutical Co., Ltd. Recent Developments
11.3 Shanghai Zhonghua Pharmaceutical Co., Ltd.
11.3.1 Shanghai Zhonghua Pharmaceutical Co., Ltd. Corporation Information
11.3.2 Shanghai Zhonghua Pharmaceutical Co., Ltd. Overview
11.3.3 Shanghai Zhonghua Pharmaceutical Co., Ltd. Molsidomine Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Shanghai Zhonghua Pharmaceutical Co., Ltd. Molsidomine Product Description
11.3.5 Shanghai Zhonghua Pharmaceutical Co., Ltd. Recent Developments
11.4 Beijing Hyderun Pharmaceutical Group Co., Ltd.
11.4.1 Beijing Hyderun Pharmaceutical Group Co., Ltd. Corporation Information
11.4.2 Beijing Hyderun Pharmaceutical Group Co., Ltd. Overview
11.4.3 Beijing Hyderun Pharmaceutical Group Co., Ltd. Molsidomine Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Beijing Hyderun Pharmaceutical Group Co., Ltd. Molsidomine Product Description
11.4.5 Beijing Hyderun Pharmaceutical Group Co., Ltd. Recent Developments
11.5 Heilongjiang Fulekang Pharmaceutical Co., Ltd.
11.5.1 Heilongjiang Fulekang Pharmaceutical Co., Ltd. Corporation Information
11.5.2 Heilongjiang Fulekang Pharmaceutical Co., Ltd. Overview
11.5.3 Heilongjiang Fulekang Pharmaceutical Co., Ltd. Molsidomine Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Heilongjiang Fulekang Pharmaceutical Co., Ltd. Molsidomine Product Description
11.5.5 Heilongjiang Fulekang Pharmaceutical Co., Ltd. Recent Developments
11.6 Taj Life Sciences
11.6.1 Taj Life Sciences Corporation Information
11.6.2 Taj Life Sciences Overview
11.6.3 Taj Life Sciences Molsidomine Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Taj Life Sciences Molsidomine Product Description
11.6.5 Taj Life Sciences Recent Developments
11.7 Sanofi
11.7.1 Sanofi Corporation Information
11.7.2 Sanofi Overview
11.7.3 Sanofi Molsidomine Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Sanofi Molsidomine Product Description
11.7.5 Sanofi Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Molsidomine Value Chain Analysis
12.2 Molsidomine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Molsidomine Production Mode & Process
12.4 Molsidomine Sales and Marketing
12.4.1 Molsidomine Sales Channels
12.4.2 Molsidomine Distributors
12.5 Molsidomine Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Molsidomine Industry Trends
13.2 Molsidomine Market Drivers
13.3 Molsidomine Market Challenges
13.4 Molsidomine Market Restraints

14 Key Findings in The Global Molsidomine Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Molsidomine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Tablet
Table 3. Major Manufacturers of Aerosol
Table 4. Global Molsidomine Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Molsidomine Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Molsidomine Sales by Region (2016-2021) & (K Units)
Table 7. Global Molsidomine Sales Market Share by Region (2016-2021)
Table 8. Global Molsidomine Sales by Region (2022-2027) & (K Units)
Table 9. Global Molsidomine Sales Market Share by Region (2022-2027)
Table 10. Global Molsidomine Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Molsidomine Revenue Market Share by Region (2016-2021)
Table 12. Global Molsidomine Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Molsidomine Revenue Market Share by Region (2022-2027)
Table 14. Global Molsidomine Sales by Manufacturers (2016-2021) & (K Units)
Table 15. Global Molsidomine Sales Share by Manufacturers (2016-2021)
Table 16. Global Molsidomine Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Molsidomine Revenue Share by Manufacturers (2016-2021)
Table 18. Molsidomine Price by Manufacturers 2016-2021 (US$/Unit)
Table 19. Global Molsidomine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Molsidomine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molsidomine as of 2020)
Table 21. Molsidomine Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Molsidomine Product Offered
Table 23. Date of Manufacturers Enter into Molsidomine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Molsidomine Sales by Type (2016-2021) & (K Units)
Table 26. Global Molsidomine Sales by Type (2022-2027) & (K Units)
Table 27. Global Molsidomine Sales Share by Type (2016-2021)
Table 28. Global Molsidomine Sales Share by Type (2022-2027)
Table 29. Global Molsidomine Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Molsidomine Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Molsidomine Revenue Share by Type (2016-2021)
Table 32. Global Molsidomine Revenue Share by Type (2022-2027)
Table 33. Molsidomine Price by Type (2016-2021) & (US$/Unit)
Table 34. Global Molsidomine Price Forecast by Type (2022-2027) & (US$/Unit)
Table 35. Global Molsidomine Sales by Application (2016-2021) & (K Units)
Table 36. Global Molsidomine Sales by Application (2022-2027) & (K Units)
Table 37. Global Molsidomine Sales Share by Application (2016-2021)
Table 38. Global Molsidomine Sales Share by Application (2022-2027)
Table 39. Global Molsidomine Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global Molsidomine Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global Molsidomine Revenue Share by Application (2016-2021)
Table 42. Global Molsidomine Revenue Share by Application (2022-2027)
Table 43. Molsidomine Price by Application (2016-2021) & (US$/Unit)
Table 44. Global Molsidomine Price Forecast by Application (2022-2027) & (US$/Unit)
Table 45. North America Molsidomine Sales by Type (2016-2021) & (K Units)
Table 46. North America Molsidomine Sales by Type (2022-2027) & (K Units)
Table 47. North America Molsidomine Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Molsidomine Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Molsidomine Sales by Application (2016-2021) & (K Units)
Table 50. North America Molsidomine Sales by Application (2022-2027) & (K Units)
Table 51. North America Molsidomine Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America Molsidomine Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America Molsidomine Sales by Country (2016-2021) & (K Units)
Table 54. North America Molsidomine Sales by Country (2022-2027) & (K Units)
Table 55. North America Molsidomine Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Molsidomine Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Molsidomine Sales by Type (2016-2021) & (K Units)
Table 58. Europe Molsidomine Sales by Type (2022-2027) & (K Units)
Table 59. Europe Molsidomine Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Molsidomine Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Molsidomine Sales by Application (2016-2021) & (K Units)
Table 62. Europe Molsidomine Sales by Application (2022-2027) & (K Units)
Table 63. Europe Molsidomine Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe Molsidomine Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe Molsidomine Sales by Country (2016-2021) & (K Units)
Table 66. Europe Molsidomine Sales by Country (2022-2027) & (K Units)
Table 67. Europe Molsidomine Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Molsidomine Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Molsidomine Sales by Type (2016-2021) & (K Units)
Table 70. Asia Pacific Molsidomine Sales by Type (2022-2027) & (K Units)
Table 71. Asia Pacific Molsidomine Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Molsidomine Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Molsidomine Sales by Application (2016-2021) & (K Units)
Table 74. Asia Pacific Molsidomine Sales by Application (2022-2027) & (K Units)
Table 75. Asia Pacific Molsidomine Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific Molsidomine Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific Molsidomine Sales by Region (2016-2021) & (K Units)
Table 78. Asia Pacific Molsidomine Sales by Region (2022-2027) & (K Units)
Table 79. Asia Pacific Molsidomine Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Molsidomine Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Molsidomine Sales by Type (2016-2021) & (K Units)
Table 82. Latin America Molsidomine Sales by Type (2022-2027) & (K Units)
Table 83. Latin America Molsidomine Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Molsidomine Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Molsidomine Sales by Application (2016-2021) & (K Units)
Table 86. Latin America Molsidomine Sales by Application (2022-2027) & (K Units)
Table 87. Latin America Molsidomine Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America Molsidomine Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America Molsidomine Sales by Country (2016-2021) & (K Units)
Table 90. Latin America Molsidomine Sales by Country (2022-2027) & (K Units)
Table 91. Latin America Molsidomine Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Molsidomine Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Molsidomine Sales by Type (2016-2021) & (K Units)
Table 94. Middle East and Africa Molsidomine Sales by Type (2022-2027) & (K Units)
Table 95. Middle East and Africa Molsidomine Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Molsidomine Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Molsidomine Sales by Application (2016-2021) & (K Units)
Table 98. Middle East and Africa Molsidomine Sales by Application (2022-2027) & (K Units)
Table 99. Middle East and Africa Molsidomine Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Molsidomine Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Molsidomine Sales by Country (2016-2021) & (K Units)
Table 102. Middle East and Africa Molsidomine Sales by Country (2022-2027) & (K Units)
Table 103. Middle East and Africa Molsidomine Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Molsidomine Revenue by Country (2022-2027) & (US$ Million)
Table 105. AdvaCare Corporation Information
Table 106. AdvaCare Description and Major Businesses
Table 107. AdvaCare Molsidomine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 108. AdvaCare Molsidomine Product
Table 109. AdvaCare Recent Developments
Table 110. China Resources Double-Crane Pharmaceutical Co., Ltd. Corporation Information
Table 111. China Resources Double-Crane Pharmaceutical Co., Ltd. Description and Major Businesses
Table 112. China Resources Double-Crane Pharmaceutical Co., Ltd. Molsidomine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. China Resources Double-Crane Pharmaceutical Co., Ltd. Molsidomine Product
Table 114. China Resources Double-Crane Pharmaceutical Co., Ltd. Recent Developments
Table 115. Shanghai Zhonghua Pharmaceutical Co., Ltd. Corporation Information
Table 116. Shanghai Zhonghua Pharmaceutical Co., Ltd. Description and Major Businesses
Table 117. Shanghai Zhonghua Pharmaceutical Co., Ltd. Molsidomine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. Shanghai Zhonghua Pharmaceutical Co., Ltd. Molsidomine Product
Table 119. Shanghai Zhonghua Pharmaceutical Co., Ltd. Recent Developments
Table 120. Beijing Hyderun Pharmaceutical Group Co., Ltd. Corporation Information
Table 121. Beijing Hyderun Pharmaceutical Group Co., Ltd. Description and Major Businesses
Table 122. Beijing Hyderun Pharmaceutical Group Co., Ltd. Molsidomine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. Beijing Hyderun Pharmaceutical Group Co., Ltd. Molsidomine Product
Table 124. Beijing Hyderun Pharmaceutical Group Co., Ltd. Recent Developments
Table 125. Heilongjiang Fulekang Pharmaceutical Co., Ltd. Corporation Information
Table 126. Heilongjiang Fulekang Pharmaceutical Co., Ltd. Description and Major Businesses
Table 127. Heilongjiang Fulekang Pharmaceutical Co., Ltd. Molsidomine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. Heilongjiang Fulekang Pharmaceutical Co., Ltd. Molsidomine Product
Table 129. Heilongjiang Fulekang Pharmaceutical Co., Ltd. Recent Developments
Table 130. Taj Life Sciences Corporation Information
Table 131. Taj Life Sciences Description and Major Businesses
Table 132. Taj Life Sciences Molsidomine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 133. Taj Life Sciences Molsidomine Product
Table 134. Taj Life Sciences Recent Developments
Table 135. Sanofi Corporation Information
Table 136. Sanofi Description and Major Businesses
Table 137. Sanofi Molsidomine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 138. Sanofi Molsidomine Product
Table 139. Sanofi Recent Developments
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Molsidomine Distributors List
Table 143. Molsidomine Customers List
Table 144. Molsidomine Market Trends
Table 145. Molsidomine Market Drivers
Table 146. Molsidomine Market Challenges
Table 147. Molsidomine Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Molsidomine Product Picture
Figure 2. Global Molsidomine Market Share by Type in 2020 & 2027
Figure 3. Tablet Product Picture
Figure 4. Aerosol Product Picture
Figure 5. Global Molsidomine Market Share by Application in 2020 & 2027
Figure 6. Hospital
Figure 7. Pharmacy
Figure 8. Others
Figure 9. Molsidomine Report Years Considered
Figure 10. Global Molsidomine Sales 2016-2027 (K Units)
Figure 11. Global Molsidomine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Molsidomine Revenue 2016-2027 (US$ Million)
Figure 13. Global Molsidomine Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 14. Global Molsidomine Sales Market Share by Region (2016-2021)
Figure 15. Global Molsidomine Sales Market Share by Region (2022-2027)
Figure 16. North America Molsidomine Sales YoY (2016-2027) & (K Units)
Figure 17. North America Molsidomine Revenue YoY (2016-2027) & (US$ Million)
Figure 18. Europe Molsidomine Sales YoY (2016-2027) & (K Units)
Figure 19. Europe Molsidomine Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Asia-Pacific Molsidomine Sales YoY (2016-2027) & (K Units)
Figure 21. Asia-Pacific Molsidomine Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Latin America Molsidomine Sales YoY (2016-2027) & (K Units)
Figure 23. Latin America Molsidomine Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Middle East & Africa Molsidomine Sales YoY (2016-2027) & (K Units)
Figure 25. Middle East & Africa Molsidomine Revenue YoY (2016-2027) & (US$ Million)
Figure 26. The Top 10 and Top 5 Players Market Share by Molsidomine Sales in 2020
Figure 27. The Top 10 and Top 5 Players Market Share by Molsidomine Revenue in 2020
Figure 28. Molsidomine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 29. Global Molsidomine Sales Market Share by Type (2016-2027)
Figure 30. Global Molsidomine Revenue Market Share by Type (2016-2027)
Figure 31. Global Molsidomine Sales Market Share by Application (2016-2027)
Figure 32. Global Molsidomine Revenue Market Share by Application (2016-2027)
Figure 33. North America Molsidomine Sales Market Share by Type (2016-2027)
Figure 34. North America Molsidomine Revenue Market Share by Type (2016-2027)
Figure 35. North America Molsidomine Sales Market Share by Application (2016-2027)
Figure 36. North America Molsidomine Revenue Market Share by Application (2016-2027)
Figure 37. North America Molsidomine Sales Share by Country (2016-2027)
Figure 38. North America Molsidomine Revenue Share by Country (2016-2027)
Figure 39. United States Molsidomine Revenue (2016-2027) & (US$ Million)
Figure 40. Canada Molsidomine Revenue (2016-2027) & (US$ Million)
Figure 41. Europe Molsidomine Sales Market Share by Type (2016-2027)
Figure 42. Europe Molsidomine Revenue Market Share by Type (2016-2027)
Figure 43. Europe Molsidomine Sales Market Share by Application (2016-2027)
Figure 44. Europe Molsidomine Revenue Market Share by Application (2016-2027)
Figure 45. Europe Molsidomine Sales Share by Country (2016-2027)
Figure 46. Europe Molsidomine Revenue Share by Country (2016-2027)
Figure 47. Germany Molsidomine Revenue (2016-2027) & (US$ Million)
Figure 48. France Molsidomine Revenue (2016-2027) & (US$ Million)
Figure 49. U.K. Molsidomine Revenue (2016-2027) & (US$ Million)
Figure 50. Italy Molsidomine Revenue (2016-2027) & (US$ Million)
Figure 51. Russia Molsidomine Revenue (2016-2027) & (US$ Million)
Figure 52. Asia Pacific Molsidomine Sales Market Share by Type (2016-2027)
Figure 53. Asia Pacific Molsidomine Revenue Market Share by Type (2016-2027)
Figure 54. Asia Pacific Molsidomine Sales Market Share by Application (2016-2027)
Figure 55. Asia Pacific Molsidomine Revenue Market Share by Application (2016-2027)
Figure 56. Asia Pacific Molsidomine Sales Share by Region (2016-2027)
Figure 57. Asia Pacific Molsidomine Revenue Share by Region (2016-2027)
Figure 58. China Molsidomine Revenue (2016-2027) & (US$ Million)
Figure 59. Japan Molsidomine Revenue (2016-2027) & (US$ Million)
Figure 60. South Korea Molsidomine Revenue (2016-2027) & (US$ Million)
Figure 61. India Molsidomine Revenue (2016-2027) & (US$ Million)
Figure 62. Australia Molsidomine Revenue (2016-2027) & (US$ Million)
Figure 63. China Taiwan Molsidomine Revenue (2016-2027) & (US$ Million)
Figure 64. Indonesia Molsidomine Revenue (2016-2027) & (US$ Million)
Figure 65. Thailand Molsidomine Revenue (2016-2027) & (US$ Million)
Figure 66. Malaysia Molsidomine Revenue (2016-2027) & (US$ Million)
Figure 67. Latin America Molsidomine Sales Market Share by Type (2016-2027)
Figure 68. Latin America Molsidomine Revenue Market Share by Type (2016-2027)
Figure 69. Latin America Molsidomine Sales Market Share by Application (2016-2027)
Figure 70. Latin America Molsidomine Revenue Market Share by Application (2016-2027)
Figure 71. Latin America Molsidomine Sales Share by Country (2016-2027)
Figure 72. Latin America Molsidomine Revenue Share by Country (2016-2027)
Figure 73. Mexico Molsidomine Revenue (2016-2027) & (US$ Million)
Figure 74. Brazil Molsidomine Revenue (2016-2027) & (US$ Million)
Figure 75. Argentina Molsidomine Revenue (2016-2027) & (US$ Million)
Figure 76. Middle East and Africa Molsidomine Sales Market Share by Type (2016-2027)
Figure 77. Middle East and Africa Molsidomine Revenue Market Share by Type (2016-2027)
Figure 78. Middle East and Africa Molsidomine Sales Market Share by Application (2016-2027)
Figure 79. Middle East and Africa Molsidomine Revenue Market Share by Application (2016-2027)
Figure 80. Middle East and Africa Molsidomine Sales Share by Country (2016-2027)
Figure 81. Middle East and Africa Molsidomine Revenue Share by Country (2016-2027)
Figure 82. Turkey Molsidomine Revenue (2016-2027) & (US$ Million)
Figure 83. Saudi Arabia Molsidomine Revenue (2016-2027) & (US$ Million)
Figure 84. UAE Molsidomine Revenue (2016-2027) & (US$ Million)
Figure 85. Molsidomine Value Chain
Figure 86. Molsidomine Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed